Guanze Medical Information Industry (Holding) (HKG:2427) expects a maximum profit attributable to the owners of 17.5 million yuan for 2024, lower than 27.6 million yuan from 2023, a Tuesday Hong Kong bourse filing said.
The medical imaging company attributed the expected decrease to a reduction in the average selling price of the medical imaging films sold during the reporting period, resulting in the dip in gross profits.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.